Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is correcting a document amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) that appeared in the Federal Register of August 6, 2008 (73 FR 45610). FDA is correcting a paragraph designating the sponsors of approved applications for oral dosage forms of amprolium. This correction is being made to improve the accuracy of the animal drug regulations.
This rule is effective November 20, 2008.Start Further Info
FOR FURTHER INFORMATION CONTACT:
George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail: firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
For reasons set forth in this preamble, FDA is correcting 21 CFR part 520 as follows:Start List of Subjects
List of Subjects in 21 CFR Part 520End List of Subjects Start Amendment Part
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine,End Amendment Part Start Part
PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGSEnd Part Start Amendment Part
1. The authority citation forEnd Amendment Part
2. In § 520.100(b)(2), remove “Nos. 051311 and 066104” and add in its place “No. 66104”.End Amendment Part Start Signature
Dated: October 17, 2008.
Director, Center for Veterinary Medicine.
[FR Doc. E8-27646 Filed 11-19-08; 8:45 am]
BILLING CODE 4160-01-S